XML 61 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business segment information
 6 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
Business segment information

14. Business segment information

The Company’s segment information (as provided below) has been prepared based on the Company’s two global business units (“GBU”) reporting segments, Spine and Orthopedics. The accounting policies of the segments are the same as those described in the business segment information found in Note 13 to the Consolidated Financial Statements included in the 2012 Form 10-K/A.

The table below presents external net sales by GBU reporting segment. Net sales include product sales and marketing service fees. Marketing service fees, which are recorded on a net basis, are comprised of fees earned for the marketing of Trinity Evolution ®, Trinity ELITE™ and Versashield® in spine and orthopedic applications.

 

     External Net Sales by GBU  
     Three Months Ended June 30,  

(US$ in thousands)

    2013      2012      Reported
Decline		     Constant
Currency
Decline		  
            (Restated)               

Spine

           

Spine Repair Implants and Regenerative Biologics

    $ 33,953       $ 35,135         (3 )%      (10 )% 

Spine Regenerative Stimulation

      34,088         41,759         (18 )%      (21 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Spine

      68,041         76,894         (12 )%      (16 )% 

Orthopedics

      30,239         36,529         (17 )%      (5 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Net Sales

    $ 98,280       $ 113,423         (13 )%      (12 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

 

     External Net Sales by GBU  
     Six Months Ended June 30,  

(US$ in thousands)

    2013      2012      Reported
Decline		     Constant
Currency
Decline		  
            (Restated)               

Spine

           

Spine Repair Implants and Regenerative Biologics

    $ 70,233       $ 69,528         1  %      1  % 

Spine Regenerative Stimulation

      67,832         80,549         (16 )%      (16 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Spine

      138,065         150,077         (8 )%      (8 )% 

Orthopedics

      63,588         72,282         (12 )%      (11 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Net Sales

    $ 201,653       $ 222,359         (9 )%      (10 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

The table below presents operating income (loss) by GBU reporting segment:

 

Operating Income (Loss) by GBU    Three Months Ended
June 30,		     Six Months Ended
June 30,		  

(US$ in thousands)

    2013     2012     2013     2012  
           (Restated)           (Restated)  

Spine

    $ 15,440      $ 16,278      $ 30,121      $ 38,297   

Orthopedics

      (1,110 )      2,521        930        2,592   

Corporate

      (5,526 )      (4,501 )      (14,160 )      (8,671 ) 
  

 

 

    

 

 

    

 

 

    

 

 

  

Total

    $ 8,804      $ 14,298      $ 16,891      $ 32,218